FDA Links Johnson & Johnson COVID Vaccine to Rare Nerve Syndrome

by Dylan Housman

The Food and Drug Administration (FDA) issued a warning Monday that the Johnson & Johnson COVID-19 vaccine could be linked to a rare neurological condition called Guillain-Barré syndrome.

FDA regulators found that recipients of the J&J shot may be three-to-five times more likely to develop the disorder than the general population. A new warning has been added to fact sheets distributed to both vaccine recipients and healthcare providers by the agency.

[…] Regulators discovered about 100 suspected cases of Guillain-Barré, 95% of which required hospitalization, according to The New York Times. The agency said it cannot yet confirm that the relationship between the syndrome and the vaccine is “causal.”

Continue Reading at DailyCaller.com…